Search

Insulet Corp

Lezárt

SzektorEgészségügy

137.83 4.57

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

131.56

Maximum

132.88

Fő mutatók

By Trading Economics

Bevétel

3.9M

95M

Értékesítés

40M

802M

P/E

Szektor átlag

27.618

56.597

Egy részvényre jutó nyereség

1.66

Profit margin

11.85

Munkavállalók

5,400

EBITDA

-22M

132M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-1.5B

10B

Előző nyitás

133.26

Előző zárás

137.83

Hangulat hírek alapján

By Acuity

64%

36%

287 / 339 Rangsor szerint Healthcare

Insulet Corp Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 10. 20:07 UTC

News

Insulet Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, contributing to a decline in shares during Thursday's session.

2026. szept. 9. 23:16 UTC

Insulet Corp shares are higher in after-market hours, gaining since Wednesday's close. This follows a recent trend of four consecutive lower finishes.

2026. szept. 8. 20:07 UTC

News
Social Media

Insulet Corp shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, targeting potential claims of corporate wrongdoing.

2026. szept. 4. 20:07 UTC

Insulet Corp's shares are lower today, reaching a session low earlier. The stock remains above its 20-day moving average amid notable volatility.

2026. szept. 3. 22:46 UTC

Insulet Corp shares are lower in after-market hours, despite earlier gains. No specific news was identified to explain the price movement.

2026. szept. 2. 19:36 UTC

Insulet Corp shares are declining today, despite an earlier peak. Broader market concerns include heightened geopolitical tensions and potential supply disruptions.

2026. szept. 1. 23:36 UTC

Insulet Corp's shares are higher in after-market hours, following notable trading activity. The stock remains above its 20-day moving average despite negative market sentiment.

2026. aug. 31. 20:07 UTC

News

Insulet Corp reported 23.5% revenue growth for Q2 2026, though it lowered FY2026 guidance. Shares are gaining today amid broader market trends.

2026. aug. 28. 19:16 UTC

Insulet Corp's shares are higher today, reflecting positive market sentiment despite earlier intraday volatility. No specific news was identified to explain the movement.

2026. aug. 27. 19:26 UTC

News

Insulet Corp faces a class action lawsuit alleging securities fraud related to manufacturing defects, contributing to a decline in shares today.

2026. aug. 26. 19:16 UTC

Social Media

Insulet Corp shares are higher today, supported by over $226,000 in December $200 call options. Recent PCE data may also influence market sentiment.

2026. aug. 25. 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

2026. aug. 24. 19:56 UTC

News

Insulet Corp shares are lower amid negative sentiment from two class action lawsuits alleging securities fraud related to product safety concerns.

2026. aug. 21. 19:56 UTC

Insulet Corp shares are higher today, reflecting positive market momentum. Broader market gains, particularly in cryptocurrency, contribute to the stock's upward movement.

2026. aug. 20. 23:11 UTC

Insulet Corp shares are trading lower in after-market hours, continuing a decline that follows a reversal from earlier highs. No specific news was identified.

2026. aug. 19. 23:01 UTC

Insulet Corp shares are higher in after-market trading, continuing a trend of gains over the last three sessions without any specific news driving the movement.

2026. aug. 18. 20:03 UTC

Insulet Corp's shares are higher today, having previously peaked before pulling back. The stock has advanced since Monday's close, despite no specific news.

2026. aug. 17. 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

2026. aug. 14. 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

2026. aug. 13. 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

2026. aug. 12. 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

2026. aug. 11. 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

2026. aug. 10. 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

2026. aug. 7. 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

2026. aug. 6. 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

2026. aug. 5. 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

2026. aug. 4. 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

2026. aug. 3. 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

2026. júl. 31. 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

2026. júl. 29. 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

Társak összehasonlítása

Árváltozás

Insulet Corp Előrejelzés

Értékelési konszenzus

By TipRanks

Mérsékelt vétel

20 ratings

11

Vétel

9

Tartás

0

Eladás

Hangulat

By Acuity

287 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bearish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat